Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
telmisartan, Quantity: 80 mg; hydrochlorothiazide, Quantity: 12.5 mg
Alembic Pharmaceuticals Australia Pty Ltd
Hydrochlorothiazide,Telmisartan
Tablet, multilayer
Excipient Ingredients: lactose monohydrate; magnesium stearate; povidone; sodium hydroxide; mannitol; meglumine; sodium stearylfumarate; purified water; iron oxide red
Oral
28
(S4) Prescription Only Medicine
TELMISARTAN HCT APEL is indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.
Visual Identification: Oblong biconvex bilayered uncoated tablets with one white/off white color layer and one pink colour mottled layer debossed with L200; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2016-08-19